FDA Grants , Priority Review to, Pfizer's COVID-19 Vaccine.<br />On July 16, the U.S. Food and Drug Administration (FDA) announced that the Pfizer/BioNTech COVID-19 vaccine has been granted priority review for full approval.<br />On July 16, the U.S. Food and Drug Administration (FDA) announced that the Pfizer/BioNTech COVID-19 vaccine has been granted priority review for full approval.<br />The goal is to have a decision <br />from the FDA by January 2022.<br />Typically, the priority review process takes <br />six months, but it could come sooner.<br />Andy Slavitt, former <br />White House senior adviser <br />for COVID-19 response, <br />said approval could come <br />as early as July, although <br />it's a detailed process.<br />There's a lot of moving pieces. It's not as easy. Hopefully in the next four to five weeks, and I think that will be very, very good news, Andy Slavitt, to CNN's Alisyn Camerota.<br />Pfizer and BioNTech submitted a <br />Biologics License Application for their <br />vaccine for people ages 16 and up in May
